BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 25632196)

  • 1. Survival in gastric cancer in relation to postoperative adjuvant therapy and determinants.
    Ozden S; Ozgen Z; Ozyurt H; Gemici C; Yaprak G; Tepetam H; Mayadagli A
    World J Gastroenterol; 2015 Jan; 21(4):1222-33. PubMed ID: 25632196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic value of the lymph node ratio for local advanced gastric cancer patients with intensity-modulated radiation therapy and concurrent chemotherapy after radical gastrectomy in China.
    Yang Y; Ma Y; Xiang X; Xing P; Wu Y; Zhang L; Tian Y
    Radiat Oncol; 2020 Oct; 15(1):237. PubMed ID: 33054848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoradiotherapy versus chemotherapy as adjuvant treatment for localized gastric cancer: a propensity score-matched analysis.
    Girardi DM; de Lima MA; Pereira GCB; Negrão MV; López RVM; Capareli FC; Sabbaga J; Hoff PMG
    BMC Cancer; 2018 Apr; 18(1):378. PubMed ID: 29614980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there a role for surgery with adequate nodal evaluation alone in gastric adenocarcinoma?
    Dudeja V; Habermann EB; Abraham A; Zhong W; Parsons HM; Tseng JF; Al-Refaie WB
    J Gastrointest Surg; 2012 Feb; 16(2):238-46; discussion 246-7. PubMed ID: 22089951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Tumor Budding in Predicting Survival for Gastric Carcinoma Patients in Vietnam.
    Dao TV; Nguyen CV; Nguyen QT; Vu HTN; Phung HT; Bui OT; Nguyen DK; Luong BV; Tran TV
    Cancer Control; 2020; 27(1):1073274820968883. PubMed ID: 33136444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Choosing the right adjuvant therapy for stage III-IVA endometrial cancer: A comparative analysis of chemoradiotherapy and chemotherapy.
    Kim HJ; Lee J; Lee KB; Sung K; Kim YB; Kim YS
    Gynecol Oncol; 2024 Mar; 182():39-44. PubMed ID: 38246045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized controlled study of postoperative adjuvant immunochemotherapy with Nocardia rubra cell wall skeleton (N-CWS) and Tegafur for gastric carcinoma.
    Koyama S; Ozaki A; Iwasaki Y; Sakita T; Osuga T; Watanabe A; Suzuki M; Kawasaki T; Soma T; Tabuchi T
    Cancer Immunol Immunother; 1986; 22(2):148-54. PubMed ID: 3087619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parietal cell/oncocytic gastric carcinoma: systematic review and first-time assessment of HER2 status in two new cases.
    Mavroeidis VK; Gkegkes ID; Saffioti F; Kandilaris K; Alexiou K; Horti M; Economou N; Demonakou M
    Ann R Coll Surg Engl; 2020 Apr; 102(4):300-307. PubMed ID: 31928359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of National Adoption of Evidence-Based Treatment for Resectable Gastric Adenocarcinoma.
    Lee TC; Wima K; Morris MC; Johnston ME; Shah SA; Ahmad SA; Patel SH; Wilson GC
    J Gastrointest Surg; 2021 Jan; 25(1):36-47. PubMed ID: 33201456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A meta-analysis of the association between adjuvant chemoradiotherapy and disease-free survival in gastric cancer according to the histology.
    Yildirim HC; Guven DC; Akyildiz A; Yalcin S; Dizdar O
    Ir J Med Sci; 2023 Dec; 192(6):2631-2634. PubMed ID: 36867373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of Recurrence After Poor Response to Neoadjuvant Chemotherapy in Gastric Cancer and the Role for Adjuvant Radiation.
    Hui C; Ewongwo A; Lau B; Fisher G; Delitto D; Poultsides G; Ho QA; Rahimy E; Pollom E; Chang DT; Vitzthum LK
    Ann Surg Oncol; 2024 Jan; 31(1):413-420. PubMed ID: 37755563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying the optimal treatment strategy in patients with resectable non-cardia gastric cancer.
    Ajay PS; Rajamanickam RK; Rhee K; NeMoyer R; Goyal S; Switchenko JM; Lin Y; Jabbour SK; Carpizo DR; Kennedy TJ; Shah MM
    Surg Endosc; 2024 Jan; 38(1):136-147. PubMed ID: 37935921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multimodality treatment of potentially curative gastric cancer: geographical variations and future prospects.
    Merrett ND
    World J Gastroenterol; 2014 Sep; 20(36):12892-9. PubMed ID: 25278686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of perioperative chemotherapy with adjuvant chemoradiotherapy for resectable gastric cancer: findings from a population-based study.
    Jabo B; Selleck MJ; Morgan JW; Lum SS; Bahjri KA; Aljehani M; Garberoglio CA; Reeves ME; Namm JP; Solomon NL; Luca F; Dyke C; Senthil M
    J Gastrointest Oncol; 2018 Feb; 9(1):35-45. PubMed ID: 29564169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Peritoneal Recurrence of Gastric Cancer Treated with Chemoradiotherapy-A Case Report].
    Koh M; Ebisui C; Yamada Y; Hayashi K; Hara A; Takeyama H; Katsura Y; Hirose H; Tanaka N; Yoshioka S; Okamura S; Yokouchi H; Yano M
    Gan To Kagaku Ryoho; 2023 Dec; 50(13):1724-1726. PubMed ID: 38303186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of different treatment strategies for T3N1-3 stage gastric cancer based on the SEER database.
    Tan Y; Liu S; Tao S; Cheng H; Huang M; Tang Q
    Sci Rep; 2024 May; 14(1):11210. PubMed ID: 38755237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elderly patients with stage II gastric cancer do not benefit from adjuvant chemotherapy.
    Guo J; Xiong Z; Yin S; Wen Y; Jin L; Wang C; Chen H; Luo D; Deng Z; Huang D; Li X; Yi B; Mao C; Lian L
    World J Surg Oncol; 2023 Oct; 21(1):319. PubMed ID: 37821872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycosidically bound sialic acid levels as a predictive marker of postoperative adjuvant therapy in gastric cancer.
    Ogoshi K; Kondoh Y; Tajima T; Mitomi T
    Cancer Immunol Immunother; 1992; 35(3):175-80. PubMed ID: 1638553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of nodal status in determining multimodal treatment strategies in non-cardia gastric cancer.
    Ajay PS; Sok CP; Goyal S; Switchenko JM; Maegawa FB; Gillespie TW; Paulos CM; Lesinski GB; Kooby DA; Kennedy TJ; Shah MM
    J Surg Oncol; 2023 Aug; 128(2):242-253. PubMed ID: 37114465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative adjuvant immunotherapy of gastric cancer with BCG-cell wall skeleton. 3- to 6-year follow up of a randomized clinical trial.
    Ochiai T; Sato H; Hayashi R; Asano T; Sato H; Yamamura Y
    Cancer Immunol Immunother; 1983; 14(3):167-71. PubMed ID: 6340825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.